Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein; the discovery could lead to new therapies for blood coagulation disorders, cancers and other conditions.
Jonathan Butcher, the Joseph N. Pew Jr. Professor in Engineering in the Meinig School of Biomedical Engineering, has been named this year’s recipient of the Kaplan Family Distinguished Faculty Fellowship from the Einhorn Center.
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.
As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children.
A new study helps resolve a long-standing paradox in biology about genome architecture and cell function, which may provide insights into certain developmental disorders and cancers.
A proof of principle study in mice, six years in the making, shows how targeting a natural checkpoint in meiosis, the process by which sex cells reproduce, safely stopped sperm production.
Elisha Frye, D.V.M. ’10, explains how Cornell’s Animal Health Diagnostic Center works at the front lines of detecting and preventing diseases that can jump between animals and humans.
Researchers at Cornell University have developed a powerful new genetic toolkit that allows scientists to study how genes function at the level of individual cells, an advance that could accelerate discoveries in development, neuroscience and disease.
